Quarterly report · Q3
9627.TEDINET S100QELB
Period2022-05-01 → 2023-01-31
Filed2023-03-17
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥263.9bn | 2022-05-01 → 2023-01-31 | Cons. | Net sales |
| Revenue | ¥316.2bn | 2021-05-01 → 2022-04-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥234.6bn | 2021-05-01 → 2022-01-31 | Cons. | Net sales |
| Operating income | ¥11.7bn | 2022-05-01 → 2023-01-31 | Cons. | Operating income |
| Operating income | ¥10.2bn | 2021-05-01 → 2022-01-31 | Cons. | Operating income |
| Ordinary income | ¥12.4bn | 2022-05-01 → 2023-01-31 | Cons. | Ordinary income |
| Ordinary income | ¥16.0bn | 2021-05-01 → 2022-04-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.8bn | 2021-05-01 → 2022-01-31 | Cons. | Ordinary income |
| Profit before tax | ¥12.1bn | 2022-05-01 → 2023-01-31 | Cons. | Income before income taxes |
| Profit before tax | ¥10.7bn | 2021-05-01 → 2022-01-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.6bn | 2022-05-01 → 2023-01-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥7.1bn | 2021-05-01 → 2022-04-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.2bn | 2021-05-01 → 2022-01-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥6.6bn | 2022-05-01 → 2023-01-31 | Cons. | Profit loss |
| Net income | ¥6.2bn | 2021-05-01 → 2022-01-31 | Cons. | Profit loss |
| Total assets | ¥229.6bn | at 2023-01-31 | Cons. | Assets |
| Total assets | ¥212.5bn | at 2022-04-30 | Cons. | Assets |
| Total assets | ¥208.0bn | at 2022-01-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥105.8bn | at 2023-01-31 | Cons. | Liabilities |
| Total liabilities | ¥93.5bn | at 2022-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥123.7bn | at 2023-01-31 | Cons. | Net assets |
| Net assets / equity | ¥119.0bn | at 2022-04-30 | Cons. | Net assets |
| Net assets / equity | ¥118.1bn | at 2022-01-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥46.2bn | at 2023-01-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥59.7bn | at 2022-04-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥188.7 | 2022-05-01 → 2023-01-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.4 | 2022-11-01 → 2023-01-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.47 | 2021-05-01 → 2022-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥176.89 | 2021-05-01 → 2022-01-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.27 | 2021-11-01 → 2022-01-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 53.9% | at 2023-01-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2022-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.8% | at 2022-01-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-05-01 → 2023-01-31 | ¥8.7bn |
| Otherother segments | revenue external | 2022-05-01 → 2023-01-31 | ¥8.7bn |
| Otherother segments | revenue intersegment | 2022-05-01 → 2023-01-31 | ¥43m |
| Otherother segments | segment ordinary income | 2022-05-01 → 2023-01-31 | −¥2m |
| Reconciling Itemsreconciling | revenue | 2022-05-01 → 2023-01-31 | −¥43m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-05-01 → 2023-01-31 | −¥43m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-05-01 → 2023-01-31 | −¥6.4bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2022-05-01 → 2023-01-31 | ¥236.4bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2022-05-01 → 2023-01-31 | ¥236.4bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2022-05-01 → 2023-01-31 | ¥18.0bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2022-05-01 → 2023-01-31 | ¥18.8bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2022-05-01 → 2023-01-31 | ¥18.8bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2022-05-01 → 2023-01-31 | ¥737m |
| —segment total | revenue | 2022-05-01 → 2023-01-31 | ¥263.9bn |
| —segment total | revenue external | 2022-05-01 → 2023-01-31 | ¥263.9bn |
| —segment total | revenue intersegment | 2022-05-01 → 2023-01-31 | ¥43m |
| —segment total | segment ordinary income | 2022-05-01 → 2023-01-31 | ¥18.8bn |
| Otherother segments | revenue | 2021-05-01 → 2022-01-31 | ¥9.6bn |
| Otherother segments | revenue external | 2021-05-01 → 2022-01-31 | ¥9.5bn |
| Otherother segments | revenue intersegment | 2021-05-01 → 2022-01-31 | ¥71m |
| Otherother segments | segment ordinary income | 2021-05-01 → 2022-01-31 | −¥108m |
| Reconciling Itemsreconciling | revenue | 2021-05-01 → 2022-01-31 | −¥71m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-05-01 → 2022-01-31 | −¥71m |
| Reconciling Itemsreconciling | segment ordinary income | 2021-05-01 → 2022-01-31 | −¥5.4bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2021-05-01 → 2022-01-31 | ¥209.8bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2021-05-01 → 2022-01-31 | ¥209.8bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2021-05-01 → 2022-01-31 | ¥17.8bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2021-05-01 → 2022-01-31 | ¥15.3bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2021-05-01 → 2022-01-31 | ¥15.3bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2021-05-01 → 2022-01-31 | −¥1.5bn |
| —segment total | revenue | 2021-05-01 → 2022-01-31 | ¥234.7bn |
| —segment total | revenue external | 2021-05-01 → 2022-01-31 | ¥234.6bn |
| —segment total | revenue intersegment | 2021-05-01 → 2022-01-31 | ¥71m |
| —segment total | segment ordinary income | 2021-05-01 → 2022-01-31 | ¥16.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 380
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities and net assets | Prior1YearInstant | 212461000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 229562000000 | JPY |
| Net sales | Prior1YTDDuration | 234610000000 | JPY |
| Net sales | CurrentYTDDuration | 263906000000 | JPY |
| Cost of sales | Prior1YTDDuration | 198110000000 | JPY |
| Cost of sales | CurrentYTDDuration | 224213000000 | JPY |
| Gross profit | Prior1YTDDuration | 36500000000 | JPY |
| Gross profit | CurrentYTDDuration | 39692000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 26286000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 28006000000 | JPY |
| Operating income | Prior1YTDDuration | 10214000000 | JPY |
| Operating income | CurrentYTDDuration | 11685000000 | JPY |
| Interest income noi | Prior1YTDDuration | 31000000 | JPY |
| Interest income noi | CurrentYTDDuration | 36000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 35000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 62000000 | JPY |
| Commission fee noi | Prior1YTDDuration | 11000000 | JPY |
| Commission fee noi | CurrentYTDDuration | 12000000 | JPY |
| Real estate rent noi | Prior1YTDDuration | 334000000 | JPY |
| Real estate rent noi | CurrentYTDDuration | 151000000 | JPY |
| Fiduciary obligation fee noi | Prior1YTDDuration | 132000000 | JPY |
| Fiduciary obligation fee noi | CurrentYTDDuration | 165000000 | JPY |
| Subsidy income noi | Prior1YTDDuration | 92000000 | JPY |
| Subsidy income noi | CurrentYTDDuration | 169000000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 2000000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | － | JPY |
| Other noi | Prior1YTDDuration | 316000000 | JPY |
| Other noi | CurrentYTDDuration | 367000000 | JPY |
| Non operating income | Prior1YTDDuration | 957000000 | JPY |
| Non operating income | CurrentYTDDuration | 965000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 34000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 40000000 | JPY |
| Loss on transfer of receivables noe | Prior1YTDDuration | 63000000 | JPY |
| Loss on transfer of receivables noe | CurrentYTDDuration | 75000000 | JPY |
| Rent expenses on real estates noe | Prior1YTDDuration | 215000000 | JPY |
| Rent expenses on real estates noe | CurrentYTDDuration | 92000000 | JPY |
| Other noe | Prior1YTDDuration | 57000000 | JPY |
| Other noe | CurrentYTDDuration | 75000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 370000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 283000000 | JPY |
| Ordinary income | Prior1YTDDuration | 10800000000 | JPY |
| Ordinary income | CurrentYTDDuration | 12367000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 200000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 2000000 | JPY |
| Gain on transfer of business ei | Prior1YTDDuration | 13000000 | JPY |
| Gain on transfer of business ei | CurrentYTDDuration | 73000000 | JPY |
| Surrender value of insurance ei | Prior1YTDDuration | 4000000 | JPY |
| Surrender value of insurance ei | CurrentYTDDuration | 35000000 | JPY |
| Gain on step acquisitions ei | Prior1YTDDuration | 131000000 | JPY |
| Gain on step acquisitions ei | CurrentYTDDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |